Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Axsome (AXSM) Starts Late-Stage Study of Migraine Drug AXS-07
02:17pm, Friday, 02'nd Sep 2022
Axsome (AXSM) initiates a phase III open-label study for its pipeline candidate, AXS-07 for treating acute migraine.
15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome
01:47pm, Tuesday, 30'th Aug 2022
In recent days, biotech stocks have slowed their early-August sprint. But not all shares are ready to hit the showers.
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
08:00am, Monday, 29'th Aug 2022
Biotech stocks are scorching right now. But the best of the best have strong gains.
3 Healthcare Stocks That Are Beating the Market
09:29am, Sunday, 28'th Aug 2022
Here's why our roundtable is bullish on Shockwave Medical, Axsome Therapeutics, and Rhythm Pharmaceuticals.
3 Growth Stocks Poised to Skyrocket
06:08am, Saturday, 27'th Aug 2022
All of them could have huge catalysts on the way.
This Growth Stock Is Soaring. Is It a Buy?
09:53am, Friday, 26'th Aug 2022
It may not be too late to get in on this drugmaker.
Why Axsome Therapeutics Stock Jumped This Week
02:48pm, Thursday, 25'th Aug 2022
Wall Street is optimistic about the company's newly approved depression medication.
Axsome (AXSM) Soars on FDA Nod for Depression Drug, Auvelity
02:18pm, Monday, 22'nd Aug 2022
The FDA approves Axsome's (AXSM) Auvelity extended-release tablets for the treatment of major depressive disorder in adults. This becomes the first approved product for the company.
3 Biopharmas on Buyout Watch
08:00am, Monday, 22'nd Aug 2022
These three biotech companies could be headed for a buyout soon.
Does a New Depression Drug Make This Stock a Buy Now?
05:27am, Sunday, 21'st Aug 2022
A long-delayed announcement from the FDA was even more positive than expected.
Axsome's depression drug receives FDA approval
12:31pm, Friday, 19'th Aug 2022
#Axsome's Yahoo Finance's Brian Cheung discusses reports that a depression drug from Axsome Therapeutics has received FDA clearance.
Axsome's depression drug enters competitive market after US approval
12:10pm, Friday, 19'th Aug 2022
the Food and Drug Administration approved Axsome Therapeutics anti-depression drug Auvelity which reduces symptions as early as one week.
Why Axsome Therapeutics Stock Is Crushing It Today
11:20am, Friday, 19'th Aug 2022
The biotech's drug for major depressive disorder has been formally approved by the FDA.
Why Is Axsome Therapeutics (AXSM) Stock Up 30% Today?
09:55am, Friday, 19'th Aug 2022
Shares of Axsome Therapeutics (NASDAQ: AXSM ) are up more than 30% today on news that the biopharmaceutical company has received approval from the U.S. Food and Drug Administration (FDA) for a unique,
Axsome surges after oral depression drug gets FDA approval
08:03am, Friday, 19'th Aug 2022
The U.S. Food and Drug Administration has approved Axsome Therapeutics Inc's oral depression pill, the company said on Friday, sending its shares soaring 38% in premarket trading.
